This article summarizes expert presentations and a panel discussion on radiological protection systems for ionizing and non-ionizing radiation at an international congress. It highlights that ionizing radiation protection is mature and continually revised, while non-ionizing radiation protection lacks a comparable international framework. The authors emphasize that emerging non-ionizing technologies create complex exposure scenarios and unresolved concerns about chronic and acute exposures, calling for a more cohesive and protective framework.

An RF Safe blog post written in a first-person “Grok” voice argues that many anti-radiation phone cases are ineffective or can increase exposure by causing phones to boost transmit power. It recommends the QuantaCase™ as the best option in late 2025, claiming it “delivers on physics” and avoids common design pitfalls seen in competing products. The post references WHO’s position that low-level exposure is not proven harmful in humans while also citing animal research (e.g., NTP) and proposed mechanisms (e.g., oxidative stress) to justify precautionary use.

RF Safe presents “TruthCase™ · Clean Ether Action Hub” as a combined product-and-policy hub arguing that evidence from multiple RF health research lines supports harm occurring below current exposure limits. It promotes a proposed “S4–Mito–Spin / IFO‑VGIC” framework and a “density-gated” vulnerability map, and calls for policy actions such as changes to Section 704 and enforcement via FDA/FTC. The page frames regulatory “capture/inertia” as a key reason current limits persist, while positioning its view as a “respectable minority” in 2025.

RF Safe argues that current RF-EMF exposure standards are overly focused on thermal effects and should be replaced with a “post-thermal” regulatory paradigm that accounts for claimed non-thermal biological impacts. The piece cites a mix of mechanistic hypotheses, animal studies, epidemiology, and legal/policy developments (e.g., the 2021 D.C. Circuit EHT v. FCC decision) to support a precautionary reform agenda. It also asserts that recent WHO work in 2025 strengthens the case for tumor-related risks, though these characterizations are presented as the author’s interpretation rather than independently verified within the feed item.